Evidence map›Paper›PMID 34667568›Full record

ArticleChemical science2021

Photoprocesses of the tyrosine kinase inhibitor gefitinib: from femtoseconds to microseconds and from solution to cells.

Lorena Tamarit, Meryem El Ouardi, Inmaculada Andreu, Ignacio Vayá, Miguel A Miranda

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Lorena TamaritDepartamento de Química/Instituto de Tecnología Química UPV-CSIC, Universitat Politècnica de València Camino de Vera s/n 46022 València Spain mmiranda@qim.upv.es igvapre@qim.upv.es.ORCID https://orcid.org/0000-0001-9615-5004
Meryem El OuardiDepartamento de Química/Instituto de Tecnología Química UPV-CSIC, Universitat Politècnica de València Camino de Vera s/n 46022 València Spain mmiranda@qim.upv.es igvapre@qim.upv.es.
Inmaculada AndreuDepartamento de Química/Instituto de Tecnología Química UPV-CSIC, Universitat Politècnica de València Camino de Vera s/n 46022 València Spain mmiranda@qim.upv.es igvapre@qim.upv.es.ORCID https://orcid.org/0000-0003-3409-9443
Ignacio VayáDepartamento de Química/Instituto de Tecnología Química UPV-CSIC, Universitat Politècnica de València Camino de Vera s/n 46022 València Spain mmiranda@qim.upv.es igvapre@qim.upv.es.ORCID https://orcid.org/0000-0003-1682-9342
Miguel A MirandaDepartamento de Química/Instituto de Tecnología Química UPV-CSIC, Universitat Politècnica de València Camino de Vera s/n 46022 València Spain mmiranda@qim.upv.es igvapre@qim.upv.es.ORCID https://orcid.org/0000-0002-7717-8750
Hospital Universitari i Politècnic La Fe · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gefitinib (GFT) is a tyrosine kinase inhibitor currently used for the treatment of metastatic non-small cell lung cancer. Although it has been suggested that GFT can be phototoxic, there are no systematic studies on this issue. Here, the photosensitizing potential of GFT has been assessed by means of NRU assays and protein photooxidation. In addition, a thorough photophysical study is presented based on ultrafast transient absorption spectroscopy, fluorescence and laser flash photolysis. Transient species generated after excitation of GFT have been characterized in solution and in biological environments (

Identifiers

PMID34667568
PMCPMC8457384
OpenAlexW3180256697

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.